Recent News

• 04.01.2025 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.01.2025 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.20.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.20.2025 - Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
• 03.20.2025 - Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
• 03.04.2025 - Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
• 03.04.2025 - Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
• 03.03.2025 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.03.2025 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 02.03.2025 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 03.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - 144 Report of proposed sale of securities
• 03.20.2025 - 8-K Current report
• 03.20.2025 - EX-99.1 EX-99.1
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2025 - 4 Statement of changes in beneficial ownership of securities